4/A: Zomedica Corp. Director Amends Filing to Correct Recipient Name in Stock Appreciation Rights Grant

A Zomedica Corp. director, Rodney James Williams, amended a previous filing to correct the recipient name associated with a grant of 1,975,033 stock appreciation rights.

Summary

• Rodney James Williams, a director at Zomedica Corp., filed an amendment to a previous Form 4.
• The amendment corrects the recipient name associated with a grant of 1,975,033 stock appreciation rights.
• The stock appreciation rights have an exercise price of $0.13.
• The rights were granted on November 10, 2024, and expire on November 10, 2034.
• The underlying security is common stock.

Sentiment

Score: 7

Explanation: The document is a routine amendment to a previous filing, indicating no significant positive or negative sentiment. It is a standard administrative correction.

Industry Context

This filing is a routine disclosure related to stock-based compensation for a company director, which is common practice in publicly traded companies.

Comparison to Industry Standards

• Stock appreciation rights are a common form of equity compensation used by publicly traded companies to align the interests of management and shareholders.
• The terms of the grant, such as the exercise price and vesting schedule, are typical for such awards.
• The amendment to correct the recipient name is a standard administrative correction and does not indicate any unusual activity.

Stakeholder Impact

• The correction of the recipient name has no material impact on shareholders.

Key Dates

Keywords

Zomedica Corp, Stock Appreciation Rights, Form 4, Director, Rodney James Williams, Amendment, Beneficial Ownership, Equity Securities